Allergan Deal - The Latest Ploy

In September 2017, Allergan adopted an unprecedented strategy: it paid millions of dollars to rent the sovereign immunity of a Native American Tribe, and now claims that its patents are beyond the reach of the U.S. Patent and Trademark Office (PTO). In effect, Allergan's patents are seeking asylum on tribal lands.

Allergan Deal - The Latest Play

Download Infographic

  • Read more about IP and Patent Reform
  • Share this page to raise awareness about this issue
  • Learn more about the 2018 PACED Act which would help stop anti-competitive practices

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.